← Back
$VRNA All transactions

Verona Pharma plc

M 10b5-1 Plan

$ Value

$0

Shares

4,952

Price

$0

Filed

May 1

Insider

Name

Sinha Vikas

Title

CIK

0001337845

Roles

Director

Transaction Details

Transaction Date

2025-04-29

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

195,048

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. | The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted by the Reporting Person on November 6, 2024, solely with the intent to cover payment of the exercise price. | Consists of 74,440 Ordinary Shares represented by 9,305 ADSs. | The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. | The option is fully vested.

Filing Info

Accession No.

0001104659-25-043644

Form Type

4

Issuer CIK

0001657312

Sinha Vikas's History

Date Ticker Type Value
2026-04-16 SRRK $516K
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA M
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-10-07 VRNA D
2025-08-01 VRNA M $0

Other Insiders at VRNA (90d)

No other insider activity at this issuer in the last 90 days.